NCT05892419 (WMLTM) is a clinical trial of No intervention in Memory, sponsored by University of Chicago.

Who is sponsoring NCT05892419?

NCT05892419 is sponsored by University of Chicago.

What drugs are being tested in NCT05892419?

Interventions in NCT05892419: No intervention.

What condition does NCT05892419 study?

NCT05892419 studies Memory, EEG.

Is NCT05892419 still recruiting?

NCT05892419 is currently enrolling by invitation. Last updated 9 June 2023.

Last reviewed 2023-06-09 · How we verify

NCT05892419: WMLTM

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Electrophysiological Signatures of Distinct Working Memory Subprocesses That Predict Long-term Memory Success

ENROLLING BY INVITATION Last updated 9 June 2023

What this trial tests

trial testing No intervention in Memory in 96 participants. Enrolling by invitation.

Timeline

1 July 2022

Primary endpoint
31 July 2024

31 July 2026

Quick facts

Lead sponsor	University of Chicago
Status	ENROLLING BY INVITATION
Study type	OBSERVATIONAL
Enrollment	96
Start date	1 July 2022
Primary completion	31 July 2024
Estimated completion	31 July 2026
Sites	1 location across United States

Drugs / interventions tested

No intervention

Conditions studied

Memory — all drugs for Memory →
EEG — all drugs for EEG →

Sponsor

University of Chicago

Who can join

Adults 18 to 35, any sex, with Memory or EEG. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Healthy young adults will view pictures of items while the investigators record electroencephalogram (EEG) brain activity. Then, the investigators will ask the participants to report which items the participants remember seeing. The investigators will examine how the measured brain activity relates to which pictures the participants remember.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Memory

Currently open trials in the same condition.

NCT07304375 — Effects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple Sclerosis · NA · recruiting
NCT06986122 — Virtual Contexts for Affective Modulation · NA · recruiting
NCT07208279 — Cognitive Vitality Pilot Study · NA · recruiting
NCT06889961 — Effect of Daily Mixed Spice Consumption on Memory Function · NA · recruiting
NCT06551090 — Prediction of Anxiety and Memory State · NA · recruiting

Other University of Chicago trials

Trials by the same sponsor.

NCT07346196 — A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck · Phase 2 · not yet recruiting
NCT07354100 — Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy · Phase 1, PHASE2 · not yet recruiting
NCT06446661 — Using Text Messages to Improve Oral Chemotherapy for Adolescents and Adults With Acute Lymphoblastic Leukemia · NA · not yet recruiting
NCT07179315 — A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Tr · Phase 2 · not yet recruiting
NCT07126561 — Trastuzumab Deruxtecan to Treat HER2 + Newly Diagnosed Metastatic GI Cancers · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05892419 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Chicago
Last refreshed: 9 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05892419.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing